Latest Integration News

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Lindian Resources has locked in a stable, low-cost sulphuric acid supply for its Kazakhstan processing plant, insulating its downstream rare earths strategy from China's looming export ban and volatile global markets.

BPM Minerals has completed key surveys at its Bonnie & Clyde Prospect within the Forelands Gold Project, setting the stage for maiden drilling in Q3 2026. The project’s geological complexity and strong geochemical anomalies underline its potential for a major gold discovery.

Carnavale Resources has secured a key mining lease and reported robust high-grade gold drilling results at Kookynie, keeping its Bankable Feasibility Study on track for early Q3 2026 delivery.

Platina Resources has launched an extensive 2026 drilling campaign across its Laverton gold portfolio, while advancing key acquisitions to nearly double its landholding and navigating leadership changes.

Icetana AI reported a 51% year-on-year jump in annual recurring revenue to $2.6 million but faced a $1.2 million net operating cash outflow in Q3 FY26, prompting plans for a capital raise amid expected cash flow improvements.

Castile Resources has kicked off pilot plant bench scale testing for its Rover 1 project, integrating a 41% resource upgrade and higher metal prices into its Bankable Feasibility Study. The company also secured $8.4 million in funding and is preparing for exploration drilling amid regional consolidation.

AuKing Mining has bolstered its project portfolio with the acquisition of a Tasmanian tin and silver licence and the Malawi-based Tundulu Rare Earths Project, supported by $5 million in recent equity placements.

FINEOS Corporation Holdings PLC reported its strongest quarterly cash inflow ever alongside key contract wins in Australia and North America, maintaining its FY26 revenue guidance and advancing AI integration in its insurance software platform.

Paradigm Biopharmaceuticals has upsized a $14 million placement and launched a $2 million SPP, boosting its cash runway to around $45 million. This capital injection supports the ongoing Phase 3 trial for knee osteoarthritis, with interim results expected in Q3 2026.

Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.

Viking Mines has advanced its Linka Tungsten Project by completing a conceptual process flowsheet that incorporates recent metallurgical results and enables future processing upgrades. Preliminary engineering and cost evaluations are underway ahead of planned drilling in the June quarter.